SUNESIS PHARMACEUTICALS

/SUNESIS PHARMACEUTICALS

Sunesis is a biopharmaceutical company focused on the development of novel targeted inhibitors for the treatment of hematologic and solid cancers.

Symbol

Last Closing Price
$0.84

Shares
25,000,000

Anticipated Date
July 11, 2019

Underwriters

This offering is no longer available

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange